Sotac Pharmaceuticals IPO

Sotac Pharmaceuticals IPO will open for subscription from 29 March 2023. the company aims for an issue size of ₹33.30 Cr through this IPO.

About Company

Incorporated in 2015, Sotac Pharmaceuticals is part of the SOTAC group, based in Gujarat. It is in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis. Its business is majorly on principle to principle basis with different marketers.

It caters to 162 corporate clients on a loan license and/or contract manufacturing basis. In the year 2022, the company’s manufacturing facility had an annual capacity to manufacture 360 crore tablets, 32.4 crore capsules, 2,160 Kilo Liter syrup, and 324 Tons of external preparation.

The company’s manufacturing facilities – which are WHO-GMP accredited – are situated at Sanand GIDC–II in the Ahmedabad district of Gujarat and its infrastructure consists of a comprehensive production unit, quality control department, quality assurance microbiological laboratory, raw material, and finished product storage.

Basic details about the company

Full nameSotac Pharmaceuticals Limited
IndustryPharmaceutical & Drugs
Company Website

The objective of the Issue

  • To Meet Working Capital Requirements
  • Investment in Subsidiary
  • Upgradation / Construction of Existing /New Building in the Existing Premises
  • General Corporate Purpose
  • To meet Public Issue Expenses

IPO Timetable

IPO Opening date29 March 2023
IPO Closing03 April 2023
Basis of Allotment10 April 2023
Initiation Refund11 April 2023
Credit to Demat Account12 April 2023
Listing Date13 April 2023

IPO details

Issue typeBook Built Issue IPO
IPO issue size₹33.30 Cr – 3,000,000
Fresh Issue₹33.30 Cr – 3,000,000
Offer for saleNil
Face value ₹10 per share
Price Band₹105 to ₹111 per share
Lot size1200 Shares
Retail Allocation35% 
Listing ExchangeNSE SME

IPO Lot Size

Retail (Min)11200₹133,200
Retail (Max)11200₹133,200
HNI (Min)22,400₹266,400

Reservation Details

QIB Shares Offered50% 
NII (HNI) Shares Offered15% 
Retail Shares Offered35% 

Financial Performance

 FY 2020FY 2021FY 2022H1 FY 2023
Net income0.710.862.883.10
(Amount in ₹ Crors)

Valuations & Margins

FY 2020FY 2021FY 2022
PE ratio29.33 – 31.01
RONW (%)20.9320.4343.47
ROCE (%)17.9025.4168.85
EBITDA (%)7.196.448.36

Company Promoters

  • Mr. Sharadkumar Dashrathbhai Patel
  • Mr. Dineshkumar Babulal Gelot
  • Mr. Vishalkumar Devrajbhai Patel
  • Mr. Chetankumar Bachubhai Patel
  • Mrs. Kiran Baldevbhai Jotania

Promoter Holding

Pre Issue Share Holding84.63%
Post Issue Share Holding

Lead Manager(s)

  • Beeline Capital Advisors Pvt Ltd

IPO Registrar

Selenium Tower – B, Plot 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500 032, Telangana
Phone: +91 40 6716 2222

Contact Details

Plot No. PF-21, Nr. ACME Pharma,
Opp. Teva Pharma Sanand GIDC-II,
Sanand Ahmedabad -382110, Gujarat
Phone: +91 90819 93300

Allotment Status

Sotac Pharmaceuticals IPO allotment status will be available on KFin Tech website. Click on this link to get allotment status.

Final thoughts

Sotac Pharmaceuticals IPO is going to hit Dalal street soon. applying for an IPO is purely a personal choice. study well about the company and do subscribe if you are feeling good about the company. I hope this post will give you enough details to make a fundamental study of the company. learn well and make wise decisions.

Happy Investing

Leave a Comment

Your email address will not be published. Required fields are marked *